Clinical Trial Update: S0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating iodine-131 labeled tositumomab with rituximab and chemotherapy in older patients with stage II-IV Non-Hodgkin lymphoma; results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Bexxar (tositumomab)
• Iodine-131 (Iodine-131)
• Rituxan (rituximab)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2014-02-11